News | Hypertension | November 11, 2015

AHA, AMA Call for Higher Priority on Blood Pressure Control

Evidence shows uncontrolled high blood pressure contributes to major health issues; latest research supports lower blood pressure targets to improve heart health

high blood pressure, Target BP, AMA, AHA, American Heart Association, American Medical Association

November 11, 2015 — Two of the country’s preeminent health organizations, the American Heart Association (AHA) and the American Medical Association (AMA), announced a new nationwide initiative aimed at addressing the growing burden of high blood pressure in the United States.

Target: BP will support physicians and care teams in helping their patients with high blood pressure reach a blood pressure goal of lower than 140/90 mm Hg, based on current AHA guidelines.

Although Target: BP is the first major collaborative initiative between the AHA and AMA, both organizations have long recognized high blood pressure as a major health threat. Both already have a number of practice- and community-based initiatives and online tools that are helping physicians improve blood pressure control among their patients and helping people understand and improve their high blood pressure. They’ll now synergize these efforts into a campaign that will further assist both providers and patients by enhancing high blood pressure awareness, understanding and management.

As part of Target: BP, hospitals, medical practices, practitioners and health services organizations will work to raise awareness about high blood pressure and commit to high levels of control in their patient populations. Participants will work with the latest AHA guidelines on blood pressure, aiming for readings of lower than 140/90 mm Hg for each patient, with goals adjusted as new data drives any guideline revisions in the future. AHA and AMA will provide these groups with tools and resources, including the AHA/ACC/CDC Hypertension Treatment Algorithm, for achieving this goal and will recognize those who attain high levels of control.

Even prior to the official launch, more than 50 healthcare systems or clinics serving nearly 18 million people quickly committed to participate in Target: BP, and additional ones are poised to join.

One in three American adults — about 80 million people — has high blood pressure and that number is steadily climbing, despite the fact that high blood pressure can usually be easily treated. There is a substantial body of evidence showing that high blood pressure is a contributing factor to many major health conditions, including heart attack, heart failure, stroke, kidney failure and other disease consequences.

Data from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) supports recommendations for keeping blood pressure low. The final results of SPRINT are being presented this week at the AHA’s Scientific Sessions, but previously reported preliminary findings indicated that reducing systolic blood pressure to 120 mm Hg among study participants markedly reduced the combined rate of having a heart attack, acute coronary syndrome, heart failure or stroke and reduced mortality. The study was sponsored by the National Institutes of Health and examined more than 9,300 people.

AHA President Mark Creager, M.D., said the SPRINT data is being systematically examined by the AHA/ACC Hypertension Guideline Writing Committee in consideration of any guideline revisions.

 “The SPRINT results underscore our long-standing position to detect and aggressively treat people with high blood pressure,” said Creager, director of the Heart and Vascular Center at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire “Currently, only about half of Americans with high blood pressure are achieving our recommended blood pressure reading of below 140/90 mm Hg. With Target: BP, we’ll equip healthcare providers and their patients with information and tools, to help keep blood pressure under control. By controlling blood pressure, we can potentially prevent progression to other serious threats to heart and brain health.”

 “For several years, the AMA has been keenly focused on the millions of Americans who have uncontrolled hypertension,” said AMA President Steven J. Stack, M.D. “This new collaboration will significantly build on the work we’ve already begun to improve cardiovascular health. As an emergency physician, I’ve seen first-hand the devastating impact of heart disease and I’m personally proud to be a part of a national effort that will not only save lives but help people live healthier and happier lives.”

 While fewer Americans are dying from heart disease and stroke, deaths caused by high blood pressure are on the rise, increasing 13 percent between 2001 and 2011. High blood pressure is also associated with significant economic impact, costing Americans an estimated $46 billion annually in healthcare services, medications and missed days of work

“We recognize the threat of uncontrolled blood pressure and certainly need to do a better job in helping our patients achieve blood pressure targets with lifestyle modifications as well as ideal medical therapy,” said Daniel Simon, M.D., division chief of cardiovascular medicine at UH Case Medical Center and president of the Harrington Heart and Vascular Institute at University Hospitals in northeast Ohio, an early adopter of the initiative. “Bringing evidence-based treatment approaches to our practices through Target: BP is a simple, effective way to help us renew our focus on blood pressure and bring more patients to their idea goal.”

For more information:

Related Content

Childhood Obesity and High Blood Pressure Warn of Future Heart Disease. Vivian Fornell playing doctor at the Elgin Public Library. Photo by Dave Fornell
News | Hypertension | April 30, 2020
April 30, 2020 — A large study in adolescents and children, some as young as 3 years of age, shows a link between obe
Aria CV Pulmonary Hypertension System_Aria CV PH System

The Aria CV Pulmonary Hypertension System.

News | Hypertension | February 27, 2020
February 27, 2020 — Aria CV Inc.
BackBeat CNT is the flagship therapy of Orchestra BioMed Inc. It is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS).

The BackBeat CNT system is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS). 

News | Hypertension | October 10, 2019
October 10.
Abnormal Blood Pressure in Middle And Late Life Influences Dementia Risk

Image courtesy of the American Heart Association

News | Hypertension | August 20, 2019
In a study that spanned two and a half decades and looked at data from more than 4,700 participants, Johns Hopkins...
Blood Pressure Control Less Likely Among Those Treated in Low-income Areas
News | Hypertension | August 14, 2019
People enrolled in a large clinical hypertension management trial were half as likely to control their blood pressure ...
Pediatricians Assess How to Personalize Hypertension Treatment in Children
News | Hypertension | July 29, 2019
High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians...
BackBeat Cardiac Neuromodulation Therapy Shows Immediate, Substantial Blood Pressure Reduction
News | Hypertension | June 04, 2019
Orchestra BioMed Inc. announced the presentation of two-year clinical data from the European Moderato I study of...
St. Bartholomew's Hospital Initiates CALM-2 Hypertension Trial
News | Hypertension | February 20, 2019
California-based Vascular Dynamics Inc. (VDI) is sponsoring a new clinical trial, called CALM-2 (Controlling And...